BENDHEIM JACK 4
4 · PHIBRO ANIMAL HEALTH CORP · Filed Apr 23, 2026
Research Summary
AI-generated summary of this filing
Phibro (PAHC) 10% Owner Jack Bendheim Sells Shares
What Happened
- Jack Bendheim, a 10% owner, director and officer of Phibro Animal Health Corp (PAHC), sold a total of 21,120 shares in open-market transactions across April 21–23, 2026 for aggregate proceeds of about $1,157,092. Individual reported transactions:
- 4/21/2026: 1,625 shares at $55.35 — $89,944
- 4/21/2026: 5,415 shares at $56.17 — $304,137
- 4/22/2026: 7,040 shares at $54.29 — $382,185
- 4/23/2026: 6,619 shares at $54.07 — $357,857
- 4/23/2026: 421 shares at $54.56 — $22,969
- These were sales (not purchases), which are commonly routine disposition transactions; they do not imply company performance or insider sentiment on their own.
Key Details
- Transaction dates and prices: Apr 21–23, 2026; per-trade prices and totals listed above. Several prices are reported as weighted averages (see footnotes for price ranges).
- Total sold: 21,120 shares for ≈ $1,157,092.
- Shares owned after transaction: Not specified in the Form 4; filing reports that some securities are held directly by BFI Co., LLC and some directly by Mr. Bendheim (see footnotes).
- Notable footnotes:
- F1: Sales effected pursuant to a Rule 10b5‑1 trading plan adopted by BFI Co., LLC on Dec 11, 2025 (pre‑scheduled sales).
- F2–F7: Prices are weighted averages; the shares were sold in multiple trades at prices in the ranges noted in the filing.
- F3/F8: Some reported securities are directly held by BFI (BFI is controlled by Mr. Bendheim) and some are directly held by Mr. Bendheim; he disclaims beneficial ownership except to the extent of his pecuniary interest.
- Filing timeliness: Form 4 was filed on Apr 23, 2026 covering transactions Apr 21–23, 2026; the filing shows no indication of being late.
Context
- These sales were executed under a Rule 10b5‑1 plan, which typically means they were pre‑arranged and scheduled in advance rather than opportunistic market timing by the insider. As a 10% owner and controller of BFI, Mr. Bendheim’s transactions reflect dispositions by an affiliated entity as well as direct holdings reported in the filing.
Insider Transaction Report
Form 4
BENDHEIM JACK
DirectorPresident and CEO10% Owner
Transactions
- Sale
Class A Common Stock
[F1][F2][F3]2026-04-21$55.35/sh−1,625$89,944→ 115,375 total(indirect: See) - Sale
Class A Common Stock
[F1][F4][F3]2026-04-21$56.17/sh−5,415$304,137→ 109,960 total(indirect: See) - Sale
Class A Common Stock
[F1][F5][F3]2026-04-22$54.29/sh−7,040$382,185→ 102,920 total(indirect: See) - Sale
Class A Common Stock
[F1][F6][F3]2026-04-23$54.07/sh−6,619$357,857→ 96,301 total(indirect: See) - Sale
Class A Common Stock
[F1][F7][F3]2026-04-23$54.56/sh−421$22,969→ 95,880 total(indirect: See)
Holdings
- 16,840
Class A Common Stock
[F8]
Footnotes (8)
- [F1]The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC ("BFI") on December 11, 2025.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.905 to $55.88. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5, 6 and 7.
- [F3]The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.91 to $56.56.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.73 to $54.665.
- [F6]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.51 to $54.50.
- [F7]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.515 to $54.61.
- [F8]The reported securities are directly held by Jack Bendheim.